Overview

BIBF 1120 and RAD001 in Solid Tumors - Phase I

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
BIBF1120 and RAD001 in solid tumors
Phase:
Phase 1
Details
Lead Sponsor:
University of Cologne
Collaborator:
Boehringer Ingelheim
Treatments:
Everolimus
Nintedanib
Sirolimus